ArticleDisease markers2021
NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma.
Yan Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleDisease markers2021
Yan Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.